Coloplast AS (OTCPK:CLPBF)
$ 132.475 2.475 (1.9%) Market Cap: 30.31 Bil Enterprise Value: 32.91 Bil PE Ratio: 40.31 PB Ratio: 11.67 GF Score: 93/100

Q2 2024 Coloplast A/S Earnings Call Transcript

May 07, 2024 / 07:00AM GMT
Release Date Price: $120.88 (+0.53%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining Coloplast Interim Financial Statements For H1 2023/'24 Conference Call. (Operator Instructions) I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead.

Kristian Villumsen;S;President;CEO
Coloplast A

/-&

Thank you very much, operator. Good morning, everybody, and welcome to our Half Year '23/'24 conference call. My name is Kristian Villumsen, I'm the CEO of Coloplast and I'm joined by our CFO, Anders Lonning-Skovgaard, and our Investor Relations team. We'll start like we usually do, with a short presentation by Anders and myself, and then we will open up for questions.

Please turn to Slide #3. We delivered 8% organic growth and a reported EBIT margin before special items up 27% in the second quarter. Return on invested capital after tax and before special items was 15% reflecting impact from the acquisition of Kerecis. I'm satisfied with our performance. We continue to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot